Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Tempest Therapeutics Inc (TPST)
Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,252
  • Shares Outstanding, K 19,247
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,710 K
  • 60-Month Beta -1.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TPST with:

Options Overview Details

View History
  • Implied Volatility 169.25% ( -7.56%)
  • Historical Volatility 57.61%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 350.78% on 10/24/23
  • IV Low 169.25% on 02/22/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 1,443
  • Volume Avg (30-Day) 1,158
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 11,896
  • Open Int (30-Day) 12,429

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.38
  • Number of Estimates 4
  • High Estimate -0.32
  • Low Estimate -0.43
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +39.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.46 +9.83%
on 01/30/24
4.47 -14.99%
on 02/08/24
-0.24 (-5.94%)
since 01/22/24
3-Month
2.88 +31.94%
on 12/11/23
4.92 -22.76%
on 12/28/23
-0.39 (-9.31%)
since 11/22/23
52-Week
0.17 +2,135.29%
on 10/10/23
9.77 -61.11%
on 10/11/23
+2.08 (+120.93%)
since 02/22/23

Most Recent Stories

More News
MarketBeat Week in Review – 10/16 - 10/20

All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control

HRL : 30.28 (+1.82%)
CPB : 42.20 (-0.94%)
LMND : 17.69 (+3.81%)
UAA : 8.40 (+1.57%)
VFS : 5.08 (-3.42%)
TSLA : 197.41 (+1.36%)
TXN : 165.43 (+0.82%)
META : 486.13 (+3.87%)
DLTR : 144.76 (-0.46%)
NFLX : 588.47 (+2.64%)
DXCM : 117.50 (+0.95%)
TPST : 3.80 (+4.11%)
The Secrets Behind a 4000% Biotech Stock Surge

Last Wednesday, shares of Tempest Therapeutics (NASDAQ: TPST), a small-cap stock you have probably never heard of, surged over 4000%.

TPST : 3.80 (+4.11%)
Exploring What Led to a 3,000% Surge in Shares of Tempest Therapeutics (NASDAQ: TPST)

Tempest Therapeutics, Inc. (NASDAQ: TPST) recently captivated investors with an unprecedented surge of over 3,000% in less than a week.

TPST : 3.80 (+4.11%)
Navigating the Roller Coaster of Recent Penny Stock Surges

Recent surges in penny stocks, like Secoo (SECO), Tempest Therapeutics (TPST), and OpGen (OPGN), have fueled speculation and excitement in penny stocks.

SECO : 0.4955 (-8.07%)
OPGN : 0.4200 (+1.79%)
TPST : 3.80 (+4.11%)
Tempest Therapeutics, Inc. (TPST) Upgraded to Buy: What Does It Mean for the Stock?

Tempest Therapeutics, Inc. (TPST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TPST : 3.80 (+4.11%)
Tempest Therapeutics (NASDAQ: TPST) Reports Strong Early Results From Phase 1b/2 Study of TPST-1120 in Hepatocellular Carcinoma

Tempest Therapeutics, Inc. (NASDAQ: TPST) is engaged as a clinical-stage oncology company, which is focused on the research and development

TPST : 3.80 (+4.11%)
Bears are Losing Control Over Tempest Therapeutics, Inc. (TPST), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for Tempest Therapeutics, Inc. (TPST), indicating that the stock has found support. This, combined with an upward trend in earnings...

TPST : 3.80 (+4.11%)
Tempest to Participate in Panel Discussion at 2022 William Blair Biotech Focus Conference

President Tom Dubensky, Ph.D., to Share Expertise on Next Generation Immuno-Oncolgy Targets...

TPST : 3.80 (+4.11%)
Tempest to Present at the Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing...

TPST : 3.80 (+4.11%)
Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting

RECIST responses observed in IO-refractory patients and in IO-resistant indications 30% ORR in patients treated at the two highest TPST-1120 doses in...

TPST : 3.80 (+4.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

See More

Key Turning Points

3rd Resistance Point 4.14
2nd Resistance Point 3.98
1st Resistance Point 3.89
Last Price 3.80
1st Support Level 3.64
2nd Support Level 3.48
3rd Support Level 3.39

See More

52-Week High 9.77
Fibonacci 61.8% 6.10
Fibonacci 50% 4.97
Fibonacci 38.2% 3.84
Last Price 3.80
52-Week Low 0.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar